Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Loliware is a materials biotechnology company that develops seaweed-based alternatives to single-use plastics. Utilizing its proprietary SEATech platform, the company creates high-performance, biodegradable materials designed to be "designed to disappear." Their primary commercial product is a seaweed-based straw that offers a plastic-like experience while being home-compostable and ocean-safe. Loliware's mission is to replace plastic at scale by leveraging regenerative seaweed farming and existing manufacturing infrastructure. The company's technology represents a significant advancement in industrial biotechnology applied to environmental sustainability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lolliware.